DIFFERENTIATED APPROACH TO ANTIBACTERIAL THERAPY OF CYSTITIS IN WOMEN
Teterina T.A., Apolikhina I.A.
References
1. Министерство здравоохранения Российской Федерации. Клинические рекомендации «Цистит у женщин». 2021. [Ministry of Health of the Russian Federation. Clinical Guidelines “Cystitis in Women”. 2021. (in Russian)].
2. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan, Italy, 2023. ISBN 978‑94‑92671‑19‑6.
3. Haddad J.M., Ubertazzi E., Cabrera O.S., Medina M., Garsia J., Rodriguez-Colorado S. et al. Latin American consensus on uncomplicated recurrent urinary tract infection–2018. Int Urogynecol J. 2020;31(1):35‑44. https://doi.org/10.1007/s00192‑019‑04079‑5.
4. De Cueto M., Aliaga L., Alós J.I., Canut A., Los-Arcos I., Martínez J.A. et al. Executive summary of the diagnosis and treatment of urinary tract infections: guidelines of the Spanish Society of Clinical Microbiology and Infections Diseases (SEIMC). Enferm Infecc Microbiol Clin. 2017;35(5):314‑20. https://doi.org/10.1016/ j.eimc.2016.11.005.
5. Choe H.-S., Lee S.-J., Yang S.S., Hamasuna R., Yamamoto S., Cho Y.-H. et al. Summary of the UAA‑AAUS guidelines for urinary tract infections. Int J Urol. 2018;25(3):175‑85. https://doi.org/10.1111/iju.13493.
6. Foster R.T. Uncomplicated urinary tract infections in women. Obstet Gynecol Clin North Am. 2008;35(2):235‑48, viii. https://doi.org/10.1016/j.ogc.2008.03.003.
7. Sivick K.E., Mobley H.L.T. Waging war against uropathogenic Escherichia coli: Winning back the urinary tract. Infect Immun. 2010;78(2):568‑85. https://doi.org/10.1128/IAI.01000‑09.
8. Bonkat G., Bartoletti R., Bruyère F., Cai T., Geerlings S.E., Köves B. et al. European Association of Urology. EAU Guidelines on Urological Infections; 2020. https://uroweb.org/wp‑content/uploads/EAU‑Guidelines‑on‑Urological‑infections‑2020.pdf
9. Kranz J., Schmidt S., Lebert C., Schneidevind L., Mandraka F., Kunze M. et al. The 2017 Update of the German Clinical Guideline on Epidemiology, Diagnostics, Therapy, Prevention, and Management of Uncomplicated Urinary Tract Infections in Adult Patients. Part II: Therapy and Prevention. Urol Int. 2018;100(3):271‑8. https://doi.org/10.1159/000487645.
10. European Association of Urology. Guidelines on Urological Infections. www.uroweb.org
11. Naber K.G., Schito G., Botto H., Palou J., Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008;54(5):1164‑75. https://doi.org/10.1016/j.eururo.2008.05.010.
12. Falagas M.E., Vouloumanou E.K., Togias A.G., Karadima M., Kapaskelis A.M., Rafailidis P.I., Athanasiou S. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta‑analysis of randomized controlled trials. J Antimicrob Chemother 2010;65(9):1862‑77. https://doi.org/10.1093/jac/dkq237.
13. Köves B., Cai T., Veeratterapillay R., Pickard R., Lam T.B., Yuan C.Y. et al. Benefits and Harms of Treatment of Asymptomatic Bacteriuria: A Systematic Review and Meta‑analysis by the European Association of Urology Urological Infection Guidelines Panel. Eur Urol. 2017; 72(6): 865‑8. https://doi.org/10.1016/ j.eururo. 2017.07.014.
14. Neho K.A.T, Castilho L.N., Reis L.O. Oral vaccine (OM‑89) in the recurrent urinary tract infection prophylaxis: A realistic systematic review with meta‑analayis. Actas Urol Esp. 2016;40(4):203‑8. https://doi.org/10.1016/j.acuro.2015.04.008.
15. Aziminia N., Hadjipavlou M., Philippou Y., Pandian S.S., Malde S., Hammadeh M.Y. Vaccines for the prevention of recurrent urinary tract infections: a systematic review. BJU Int. 2019;123(5):753‑68. https://doi.org/10.1111/bju.14606.
16. Аполихина И.А., Саидова А.С., Тетерина Т.А. Эффективность применения локальной цитокинотерапии в комплексном лечении пациенток с хроническим циститом. Акушерство и гинекология. 2019;12:167‑72. [Apolikhina I.A., Saidova A.S., Teterina T.A. Efficiency of local cytokine therapy used in the combination treatment of female patients with chronic cystitis. Obstetrics and Gynecology. 2019;(12):167‑72. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.12.167‑172.
17. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А., Палагин И.С., Камалов А.А., Аляев Ю.Г., Аполихин О.И., Пушкарь Д.Ю. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М.; 2020. 110 с. [Perepanova T.S., Kozlov R.S., Rudnov V.A., Sinyakova L.A., Palagin I.S., Kamalov A.A., Alyaev J.G., Apolikhin O.I., Pushkar D.Yu. Antimicrobial therapy and prevention of kidney, urinary tract and male genital infections. Federal clinical guidelines. Moscow; 2020. 110 p. (in Russia)].
18. Аляев Ю.Г., Глыбочко П.В., Пушкарь Д.Ю., ред. Урология. Клинические рекомендации. М.: ГЭОТАР‑Медиа; 2016. 480 с. [Alyaev Yu.G., Glybochko P.V., Pushkar D.Yu., ed. Urology. Clinical guidelines. Moscow: GEOTAR‑Media; 2016. 480 p. (in Russian)].
19. Колонтарев К.Б., Зайцев А.В., Пушкарь Д.Ю. Сравнительный анализ антибактериальной терапии острого цистита. Урология. 2013; 3:112‑22. [Kolontarev K.B., Zaitsev A.V., Pushkar D.Yu. Comparative analysis of antibacterial therapy for acute cystitis. Urologiia. 2013; 3:112‑22. (in Russian)].
20. Пушкарь Д.Ю., Зайцев А.В., Касян Г.Р., Цыбуля О.А. Обзор препаратов для лечения неосложненного цистита у женщин. Медицинский совет. 2010;7‑8:60‑6. [Pushkar D.Y., Zaytsev A.V., Kasyan G.R., Tsibulya O.A. Review of drugs for treatment of noncomplicated cystitis in women. Medical Council. 2010;7‑8:60‑6. (in Russian)].
21. Зайцев А.В., Тупикина Н.В. Рецидивирующая инфекция мочевых путей — междисциплинарная проблема. Медицинский совет. 2014;(19):36‑45. [Zaitsev A.V., Tupikina N.V. Recurrent urinary tract infection is a cross‑disciplinary problem. Medical Council. 2014;(19):36‑45. (in Russian)]. https://doi.org/10.21518/2079‑701X‑2014‑19‑36‑45.
22. Naber K.G., Алиджанов Ж.Ф. Существуют ли альтернативные методы антибактериальной терапии и профилактики неосложненных инфекций мочевыводящих путей? Урология. 2014;6:5‑13. [Naber K.G., Alidjanov J.F. Are there alternatives to antimicrobial therapy and prophylaxis of uncomplicated urinary tract infections? Urologiia. 2014;6:5‑13. (in Russian)].
23. Aghamali M., Sedighi M., Zahedi Bialvaei A., Mohammadzadeh N., Abbasian S., Ghafouri Z., Kouhsari E. Fosfomycin: mechanisms and the increasing prevalence of resistance. J Med Microbiol. 2019; 68(1):11‑25. https://doi.org/10.1099/jmm.0.000874.
24. Candel F.J., Matesanz David M., Barberán J. New perspectives for reassessing fosfomycin: applicability in current clinical practice. Rev Esp Quimioter. 2019; 32 Suppl 1(Suppl 1):1‑7.
About the Authors
Inna A. Apolikhina, Dr. Med. Sci., Professor, Head of the Department of Aesthetic Gynecology and Rehabilitation, V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; Professor at the Department of Obstetrics, Gynecology, Perinatology, and Reproductology, Institute of Professional Education, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, i_apolikhina@oparina4.ru, https://orcid.org/0000-0002-4581-6295, 117997, Russia, Moscow, Ac. Oparina str., 4.Tatyana A. Teterina, PhD, obstetrician-gynecologist of the Department of Aesthetic Gynecology and Rehabilitation, V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, t_teterina@oparina4.ru, 117997, Russia, Moscow, Ac. Oparina str., 4.
